Torno Capital, LLC Annovis Bio, Inc. Transaction History
Torno Capital, LLC
- $2.13 Trillion
- Q2 2024
A detailed history of Torno Capital, LLC transactions in Annovis Bio, Inc. stock. As of the latest transaction made, Torno Capital, LLC holds 52,500 shares of ANVS stock, worth $452,024. This represents 0.01% of its overall portfolio holdings.
Number of Shares
52,500Holding current value
$452,024% of portfolio
0.01%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ANVS
# of Institutions
48Shares Held
992KCall Options Held
642KPut Options Held
1.27M-
Vanguard Group Inc Valley Forge, PA361KShares$3.11 Million0.0% of portfolio
-
Black Rock Inc. New York, NY101KShares$867,1040.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA100KShares$861,0000.0% of portfolio
-
Geode Capital Management, LLC Boston, MA76.2KShares$656,3660.0% of portfolio
-
Quest Partners LLC New York, NY46KShares$396,0770.03% of portfolio
About Annovis Bio, Inc.
- Ticker ANVS
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,163,920
- Market Cap $70.3M
- Description
- Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease ...